Clinical Trial Update: RT-310 Safety and Feasibility BPH Study [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/Phase 2 safety and feasibility study of RT-310 for benign prostatic hyperplasia, sponsored by Resurge Therapeutics Inc., currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• RT-310

Snippet

Sponsor: Resurge Therapeutics Inc. | Conditions: BPH (Benign Prostatic Hyperplasia) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING